HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRANSPLANT-INELIGIBLE OR TRANSPLANT-DEFERRED NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) IN THE PHASE 3 CEPHEUS TRIAL

Category Primary study
ConferenceHematology, Transfusion and Cell Therapy
Year 2025
This article has no abstract
Epistemonikos ID: 6cfa6104e02b87041e430749fec89caf1d8335c0
First added on: Jan 10, 2026